Even superstars like Madonna need Sudocrem wonder balm occasionally
Tanya Sweeney: The iconic grey jar is beloved by other celebrities including Rita Ora and Amanda Holden
Actavis
Botox-maker back on big pharma merry-go-round
Cantillon: Abbvie seeks to broaden its base with $63bn bid for Allergan
Customs seizing large amounts of anti-HIV drug being ordered online
High price of medication has lead to increased numbers sourcing it abroad
Top 1000 2016: The winners, the losers and the biggest taxpayers
Ireland’s Top 1000 companies hit record profits of some €36bn in this year’s survey
Jump in global FDI linked to Irish tax inversion deals
OECD report finds FDI among top industrial countries back at pre-crash levels
US unveils new restrictions on firms moving tax affairs to Ireland
Measures have the potential to jeopardise ‘inversion’ of Pfizer with Allergan
US ‘tax inversion’ deals skew Ireland’s FDI numbers
OECD report suggests investment by Irish firms abroad hit $75 billion in first-half of 2015
Ireland’s top research and development investors revealed in EU survey
Data storage company Seagate Technology spent most on R&D at €889m
Botox maker Allergan in $66bn deal with Actavis
Allergan employs about 900 here, most at its manufacturing plant in Westport
Allergan says it has been approached by another party
Actavis rumoured to be going head-to-head with rival Valeant for botox and eyecare group
Pfizer said to be in takeover talks with Actavis
Acquisition could allow the US drugmaker to move overseas and reduce taxes
M&A activity up 31.1 per cent in first half of the year
New figures indicate M&A activity in Ireland is at its strongest since the early 2008
Valeant Pharmaceuticals continues to eye up Allergan
Canadian-based company said Allergan’s refusal to enter talks left it with no option but to go hostile
Pfizer’s designs on AstraZeneca stir tax envy among rivals
Pitching by bankers on tax inversion targets has reached fever pitch
Cantillon: Actavis clears first hurdle in $25bn Forest deal
The deal is predicated on the now familiar model of acquire, slash costs and point to advances in the share price
Ryanair buyback lifts stock almost 1%
S&P 500 index closes up on $25bn sale of Forest Laboratories to Actavis
Dublin-based Actavis to buy Forest Labs for $25 billion
Actavis will pay the equivalent of $89.48 per share for US pharma company
Elan sale vindicates rebuffing of Royalty
Perrigo deal will end uncertainty for Irish drugmaker after equity firm’s bids
Cantillon: Making sense of confusion in mid-range pharma M&A
Cluster of recent deals could each have an impact on Irish drug sector
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices